SELLAS (SLS) is a publicly traded Healthcare sector company. As of May 21, 2026, SLS trades at $8.91 with a market cap of $1.36B and a P/E ratio of -35.77. SLS moved +18.58% today. Year to date, SLS is +79.40%; over the trailing twelve months it is +362.37%. Its 52-week range spans $0.77 to $9.10. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces SLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns SLS stock?
Hedge funds tracked by Rallies that own SLS include Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for SELLAS.
SLS Key Metrics
Key financial metrics for SLS
Metric
Value
Price
$8.91
Market Cap
$1.36B
P/E Ratio
-35.77
EPS
$-0.25
Dividend Yield
0.24%
52-Week High
$9.10
52-Week Low
$0.77
Volume
300.81K
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-26.86M
Gross Margin
0.00%
Top Hedge Funds Holding SLS
Farallon Capital holds 40.00K shares of SLS, changed +0.00% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own SLS include Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for SELLAS.
Does Rallies show 13F holders for SLS?
Yes. Rallies tracks hedge fund and 13F ownership data for SLS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SLS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SLS. It does not provide personalized investment advice.
